Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Online First

June 14, 2019

Correspondence response
Response to: ‘Alcohol is not the missing link between Porphyromonas gingivalis related periodontitis and radiologic progression in early Rheumatoid arthritis’ by Hillion et al
Free

Hubert Marotte, Stéphane Paul

doi: 10.1136/annrheumdis-2019-215731

June 13, 2019

Rheumatoid arthritis
Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials

Maxime MA Verhoeven, Marjolein JH de Hair, Janneke Tekstra, Johannes WJ Bijlsma, Jacob M van Laar, Attila Pethoe-Schramm, Michelle EA Borm, Evert-Jan ter Borg, Suzanne P Linn-Rasker, Xavier M Teitsma, Floris PJG Lafeber, Johannes WG Jacobs, Paco MJ Welsing

doi: 10.1136/annrheumdis-2019-215304

June 12, 2019

Correspondence
Do the salivary glands of patients with systemic sclerosis show ultrasonographic modifications suggestive of Sjögren's syndrome?
Free

Marion Couderc, Anne Tournadre, Sylvain Mathieu, Bruno Pereira, Martin Soubrier, Jean Jacques Dubost

doi: 10.1136/annrheumdis-2019-215777
Correspondence
Drug-induced systemic lupus erythematosus: should immune checkpoint inhibitors be added to the evolving list?
Free

Emanuel Raschi, Ippazio Cosimo Antonazzo, Elisabetta Poluzzi, Fabrizio De Ponti

doi: 10.1136/annrheumdis-2019-215819
Correspondence response
Sicca: an important manifestation of damage in systemic sclerosis (SSc) and SSc-overlap syndromes. Response to ‘Do the salivary glands of patients with systemic sclerosis show ultrasonographic modifications suggestive of Sjögren's syndrome?’ by Coudrec et al
Free

Mandana Nikpour

doi: 10.1136/annrheumdis-2019-215797
Letter
Dramatic but suspensive effect of interleukin-1 inhibitors for persistent urticarial vasculitis: a French multicentre retrospective study

Thomas Bettuzzi, Alban Deroux, Marie Jachiet, Meryem-Maud Farhat, julien wipff, Marc Fabre, Laurence Bouillet, Nora Kramkimel, Selim Aractingi, Nicolas Dupin, Benjamin Terrier

doi: 10.1136/annrheumdis-2019-215605

June 11, 2019

Letter
Decreased endothelin receptor A autoantibody levels are associated with early ischaemic events in patients with giant-cell arteritis

Sebastian Klapa, Antje Müller, Andreas Koch, Harald Heidecke, Wataru Kähler, Juliane Junker, Susanne Schinke, Gabriela Riemekasten, Peter Lamprecht

doi: 10.1136/annrheumdis-2019-215341

June 08, 2019

Correspondence response
Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al

Elise van Mulligen, Johanna M W Hazes, Angelique E A M Weel, Pascal H P de Jong

doi: 10.1136/annrheumdis-2019-215641
Correspondence response
Chloroquine as alternative antimalarial in systemic lupus erythematosus: response to ‘2019 update of the EULAR recommendations for the management of SLE: don’t forget chloroquine’ by Figueroa-Parra et al
Free

Antonis Fanouriakis, George K Bertsias, Dimitrios T Boumpas

doi: 10.1136/annrheumdis-2019-215746
Correspondence
Neutrophil extracellular traps and low-density granulocytes are associated with the interferon signature in systemic lupus erythematosus, but not in antiphospholipid syndrome
Free

Lucas L van den Hoogen, Maarten van der Linden, Linde Meyaard, Ruth D E Fritsch-Stork, Joel A van Roon, Timothy RDJ Radstake

doi: 10.1136/annrheumdis-2019-215781

June 05, 2019

Rheumatoid arthritis
Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell

Masaru Takeshita, Katsuya Suzuki, Yasushi Kondo, Rimpei Morita, Yuumi Okuzono, Keiko Koga, Yoshiaki Kassai, Kanae Gamo, Maiko Takiguchi, Rina Kurisu, Hideyuki Mototani, Yukihiko Ebisuno, Akihiko Yoshimura, Tsutomu Takeuchi

doi: 10.1136/annrheumdis-2018-214885
Correspondence
Treatment of systemic lupus erythematosus: don’t forget hydroxychloroquine
Free

Martin Michaud, Florian Catros, Sophie Ancellin, Francis Gaches

doi: 10.1136/annrheumdis-2019-215799
Correspondence
Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Free

Íñigo Rua Figueroa, Celia Erausquin

doi: 10.1136/annrheumdis-2019-215778
Correspondence response
Antisynthetase antibodies in clinical laboratories: the importance of clinical correlation and indirect immunofluorescence
Free

Martin Greco, Mª Jesus García de Yébenes, Inmaculada Alarcón, Anahy María Brandy-García, Íñigo Rúa-Figueroa, Estibaliz Loza, Loreto Carmona

doi: 10.1136/annrheumdis-2019-215766
Recommendation
2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout
Free

Pascal Richette, Michael Doherty, Eliseo Pascual, Victoria Barskova, Fabio Becce, Johann castaneda, Malcolm Coyfish, Sylvie Guillo, Tim Jansen, Hein Janssens, Frédéric Lioté, Christian D Mallen, George Nuki, Fernando Perez-Ruiz, José Pimentao, Leonardo Punzi, Anthony Pywell, Alexander K So, Anne-Kathrin Tausche, Till Uhlig, Jakub Zavada, Weiya Zhang, Florence Tubach, Thomas Bardin

doi: 10.1136/annrheumdis-2019-215315

June 01, 2019

Correspondence
Can biomarkers differentiate psoriatic arthritis from osteoarthritis?
Free

Jian Tian, Chao Cheng, Fangjie Zhang

doi: 10.1136/annrheumdis-2019-215745

May 31, 2019

Correspondence
Association of proton pump inhibitors with fracture risk in patients with rheumatoid arthritis
Free

Toshihiro Sugiyama

doi: 10.1136/annrheumdis-2019-215747

May 29, 2019

Correspondence
Analysis of IL-6 measurement in patients with GCA treated with tocilizumab should consider concomitant treatment with prednisone
Free

Maxime Samson, Bernard Bonnotte

doi: 10.1136/annrheumdis-2019-215697
Correspondence response
Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA response to: ‘Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone’ by Samson et al
Free

Christoph T Berger, Thomas Daikeler

doi: 10.1136/annrheumdis-2019-215729
Correspondence
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients
Free

Marco Fornaro, Fabio Cacciapaglia, Vincenzo Venerito, Giuseppe Lopalco, Florenzo Iannone

doi: 10.1136/annrheumdis-2019-215715

May 24, 2019

Correspondence
SLE-DAS: ready for routine use?
Free

Anoop Mathew, Kavadichanda G Chengappa, Sanket Shah, Vir Singh Negi

doi: 10.1136/annrheumdis-2019-215704
Correspondence
2019 update of the EULAR recommendations for the management of SLE: don’t forget chloroquine
Free

Gabriel Figueroa-Parra, Carmen Magdalena Gamboa-Alonso, Ana Laura De-Leon-Ibarra, Dionicio Angel Galarza-Delgado

doi: 10.1136/annrheumdis-2019-215716

May 22, 2019

Correspondence response
Disease activity and organ damage: different sides of the same coin in systemic sclerosis
Free

Mandana Nikpour On behalf of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI) Working Group

doi: 10.1136/annrheumdis-2019-215639
Correspondence
Differentiating disease activity from damage in systemic sclerosis: it’s still early days!
Free

Siddharth Jain, Shefali Khanna Sharma

doi: 10.1136/annrheumdis-2019-215588
Correspondence
Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Jones et al
Free

Frédéric Alain Vandergheynst, Christophe Lelubre

doi: 10.1136/annrheumdis-2019-215647

May 17, 2019

Correspondence
Interosseous tendon inflammation of rheumatoid arthritis: what's the real meaning?
Free

Zhenhan Deng, Haifeng Liu, Wei Lu

doi: 10.1136/annrheumdis-2019-215559
Correspondence response
Response to: ‘Interosseous tendon inflammation of rheumatoid arthritis: what's the real meaning?’ by Deng et al
Free

Kulveer Mankia, Maria-Antonietta D'Agostino, Jorge Murillo-González, Andrew Grainger, Paul Emery

doi: 10.1136/annrheumdis-2019-215611

May 16, 2019

Correspondence
Response to: ‘Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis’ by Sabbagh et al
Free

Zaixing Yang, Yan Liang

doi: 10.1136/annrheumdis-2019-215678
Correspondence response
Response to: ‘Blood plasma versus serum: which is right for sampling circulating membrane microvesicles in human subjects?’ by Liu et al
Free

Yasuhiro Kato, JeongHoon Park, Hyota Takamatsu, Atsushi Kumanogoh

doi: 10.1136/annrheumdis-2019-215540

May 15, 2019

Correspondence
Decision-making value of nuclear dense fine speckled pattern in systemic autoimmune rheumatic disease: trick or treat?
Free

Chuiwen Deng, Xiaohui Qu, Shaoyun Cheng, Xiaofeng Zeng, Yongzhe Li, Yunyun Fei

doi: 10.1136/annrheumdis-2019-215587
Correspondence response
Response to ‘Decision making value of nuclear dense fine speckled pattern in systemic autoimmune rheumatic disease: trick or treat?’ by Deng et al
Free

Luis Eduardo Coelho Andrade, Jan Damoiseaux, Edward K Chan

doi: 10.1136/annrheumdis-2019-215640

May 14, 2019

Correspondence response
Response to: ‘The utility of the HEp-2000 antinuclear antibody substrate’ by Lee et al
Free

Jan Damoiseaux, Edward K Chan

doi: 10.1136/annrheumdis-2019-215610
Correspondence
Utility of the HEp-2000 antinuclear antibody substrate
Free

Adrian Y S Lee, Dimitra Beroukas, Peter J Roberts-Thomson

doi: 10.1136/annrheumdis-2019-215519
Correspondence
Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero
Free

Hasan Satış, Reyhan Bilici Salman, Aslihan Avanoğlu Güler, Hazan Karadeniz, Şeyma Yıldız, Neslihan Kayahan

doi: 10.1136/annrheumdis-2019-215542

May 10, 2019

Correspondence
How to use the Lupus Low Disease Activity State (LLDAS) in clinical trials
Free

Ioannis Parodis, Mandana Nikpour

doi: 10.1136/annrheumdis-2019-215650
Correspondence response
Response to ‘Antinuclear antibodies by indirect immunofluorescence and solid phase assays’ by Bossuyt et al
Free

David S Pisetsky, Diane M Spencer, Peter E Lipsky, Brad H Rovin

doi: 10.1136/annrheumdis-2019-215479
Correspondence
Antinuclear antibodies by indirect immunofluorescence and solid phase assays
Free

Xavier Bossuyt, Jolien Claessens, Ellen De Langhe, Thibaut Belmondo, Rene Westhovens, Sophie Hue, Koen Poesen, Daniel Blockmans, Michael Mahler, Marvin J Fritzler

doi: 10.1136/annrheumdis-2019-215443
Letter
Refractory sarcoidosis-like systemic granulomatosis responding to ruxolitinib

Michael Levraut, Nihal Martis, Philippe Viau, Felipe Suarez, Viviane Queyrel

doi: 10.1136/annrheumdis-2019-215387

May 09, 2019

Correspondence
TARA study: a new perspective on tapering drugs in RA
Free

Debashish Mishra, Arghya Chattopadhyay, Sanjay Jain, Varun Dhir

doi: 10.1136/annrheumdis-2019-215594
Correspondence response
Response to: ‘Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from the STRASS study’ by Marotte et al
Free

Merel J l'Ami, Charlotte L Krieckaert, Michael T Nurmohamed, Ronald F van Vollenhoven, Theo Rispens, Maarten Boers, Gerrit Jan Wolbink

doi: 10.1136/annrheumdis-2019-215609

May 08, 2019

Correspondence response
Response to: ‘Response to: ‘Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria’ by Greco et al’ by Knitza et al
Free

Anna Tjärnlund, Ingrid E Lundberg

doi: 10.1136/annrheumdis-2019-215515

May 02, 2019

Correspondence
Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from STRASS study
Free

Hubert Marotte, Mélanie Rinaudo-Gaujous, Cécile Petiet, Bruno Fautrel, Stéphane Paul

doi: 10.1136/annrheumdis-2019-215546
Correspondence response
Response to: ‘Regarding microRNA-181a-5p antisense oligonucleotides attenuate osteoarthritis in facet and knee joints’ by Liebling
Free

Akihiro Nakamura, Jason S. Rockel, Mohit Kapoor

doi: 10.1136/annrheumdis-2019-215509
Correspondence
Regarding micro-RNA-181a-5p antisense oligonucleotides attenuate osteoarthritis in facet and knee joints
Free

Michael R Liebling

doi: 10.1136/annrheumdis-2019-215454
Correspondence
Letter in response to the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al
Free

Nathalie Costedoat-Chalumeau, David Isenberg, Michelle Petri

doi: 10.1136/annrheumdis-2019-215573
Letter
Difficulties making a fist in clinically suspect arthralgia: an easy applicable phenomenon predictive for RA that is related to flexor tenosynovitis

Fenne Wouters, Florus J van der Giesen, Xanthe M E Matthijssen, Ellis Niemantsverdriet, Annette H M van der Helm-van Mil

doi: 10.1136/annrheumdis-2019-215402

April 30, 2019

Correspondence
What rheumatologist should know about Fabry disease
Free

Sergey Moiseev, Ekaterina Karovaikina, Pavel I Novikov, Dilyara Ismailova, Alexey Moiseev, Nikolai Bulanov

doi: 10.1136/annrheumdis-2019-215476
Correspondence
Can IL-1 be used as a target for osteoarthritis?
Free

Chao Cheng, Jian Tian, Fangjie Zhang

doi: 10.1136/annrheumdis-2019-215513
Correspondence response
Response to ‘What rheumatologist should know about Fabry disease’ by Moiseev et al
Free

Stefan Vordenbäumen, Ralph Brinks, Jutta G Richter, Katinka Albrecht, Matthias Schneider

doi: 10.1136/annrheumdis-2019-215516

April 29, 2019

Correspondence
Antinuclear antibodies mitotic patterns and their clinical associations
Free

Juan F Betancur, José A Gómez-Puerta

doi: 10.1136/annrheumdis-2019-215428

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

June 14, 2019

June 13, 2019

June 12, 2019

June 11, 2019

June 08, 2019

June 05, 2019

June 01, 2019

May 31, 2019

May 29, 2019

May 24, 2019

May 22, 2019

May 17, 2019

May 16, 2019

May 15, 2019

May 14, 2019

May 10, 2019

May 09, 2019

May 08, 2019

May 02, 2019

April 30, 2019

April 29, 2019

Pages